Oliver Peters
Oliver Peters
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
SM Lehmann, C Krüger, B Park, K Derkow, K Rosenberger, J Baumgart, ...
Nature neuroscience 15 (6), 827-835, 2012
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood
S Memczak, P Papavasileiou, O Peters, N Rajewsky
PloS one 10 (10), e0141214, 2015
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
H Barthel, HJ Gertz, S Dresel, O Peters, P Bartenstein, K Buerger, ...
The Lancet Neurology 10 (5), 424-435, 2011
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
J Vom Berg, S Prokop, KR Miller, J Obst, RE Kälin, I Lopategui-Cabezas, ...
Nature medicine 18 (12), 1812-1819, 2012
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease
L Jones, PA Holmans, ML Hamshere, D Harold, V Moskvina, D Ivanov, ...
PloS one 5 (11), e13950, 2010
Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat
O Peters, T Back, U Lindauer, C Busch, D Megow, J Dreier, U Dirnagl
Journal of cerebral blood flow & metabolism 18 (2), 196-205, 1998
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐and high‐CSF Aβ40 load
J Wiltfang, H Esselmann, M Bibl, M Hüll, H Hampel, H Kessler, L Frölich, ...
Journal of neurochemistry 101 (4), 1053-1059, 2007
Different mechanisms promote astrocyte Ca2+ waves and spreading depression in the mouse neocortex
O Peters, CG Schipke, Y Hashimoto, H Kettenmann
Journal of Neuroscience 23 (30), 9888-9896, 2003
Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain
S Jander, M Schroeter, O Peters, OW Witte, G Stoll
Journal of Cerebral Blood Flow & Metabolism 21 (3), 218-225, 2001
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
P Lewczuk, H Kamrowski-Kruck, O Peters, I Heuser, F Jessen, J Popp, ...
Molecular psychiatry 15 (2), 138-145, 2010
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
M Wagner, S Wolf, FM Reischies, M Daerr, S Wolfsgruber, F Jessen, ...
Neurology 78 (6), 379-386, 2012
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
JM Bader, PE Geyer, JB Müller, MT Strauss, M Koch, F Leypoldt, ...
Molecular systems biology 16 (6), e9356, 2020
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
F Jessen, A Spottke, H Boecker, F Brosseron, K Buerger, C Catak, ...
Alzheimer's research & therapy 10, 1-10, 2018
Activity-dependent ATP-waves in the mouse neocortex are independent from astrocytic calcium waves
B Haas, CG Schipke, O Peters, G Söhl, K Willecke, H Kettenmann
Cerebral cortex 16 (2), 237-246, 2006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20